Podcasts about uthealth houston

Dr. Ezra Schwartz (@ezraschwartz10) interviews Dr. Firas Moussa and Mr. Jake Howitt to discuss the IMPROVE-AD Trial, a landmark, multi-institutional study investigating treatment strategies for uncomplicated Type B Aortic Dissection (uTBAD). The IMPROVE-AD Trial is a multicenter randomized trial funded by the NIH/NHLBI that compares thoracic endovascular aortic repair (TEVAR) plus optimal medical therapy (OMT) vs. OMT and surveillance with selective TEVAR in patients with uncomplicated TBAD. The trial aims to address critical gaps in evidence left by prior studies (INSTEAD-XL, ADSORB), with a unique focus on quality of life, cost-effectiveness, and genetic data. Dr. Firas Mussa is a professor and the Chief of Vascular and Endovascular Surgery at McGovern Medical School at UTHealth Houston. He previously served as the Director of the Vascular Surgery Residency and Fellowship programs at NYU Langone Health. Dr. Mussa earned his medical degree from the University of Baghdad, followed by general surgery training at Johns Hopkins University and a vascular surgery fellowship at Baylor College of Medicine. His research focuses on complex aortic pathology, and he serves as the principal investigator of the IMPROVE AD trial. Mr. Jake Howitt is the Community Engagement Co-Chair of the IMPROVE AD trial and a leading patient advocate within the PCORI-funded Aortic Dissection Collaborative. As a survivor of aortic dissection, he is passionate about improving patient-provider communication and raising awareness of hereditary aortic disease. His work emphasizes the importance of education, empathy, and community-building in clinical research and care delivery. Special thank you to Jacob Soucy (@JacobWSoucy). Resources: ·       Treatment of Uncomplicated Type B Aortic Dissection: Optimal Medical Therapy vs TEVAR + Optimal Medical Therapy- https://journals.sagepub.com/doi/10.1177/15385744231184671?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed  ·       INSTEAD Trial - https://pubmed.ncbi.nlm.nih.gov/19996018/ ·       INSTEAD-XL 5-Year Follow-Up - https://pubmed.ncbi.nlm.nih.gov/23922146/ ·       ADSORB Trial - https://pubmed.ncbi.nlm.nih.gov/24962744/ ·       Feasibility of a proposed randomized trial in patients with uncomplicated descending thoracic aortic dissection: Results of worldwide survey - https://pubmed.ncbi.nlm.nih.gov/27823685/ ·       Treatment of AD: Meta-Analysis - https://pubmed.ncbi.nlm.nih.gov/29066151/ ·       TEVAR vs Medical Therapy- https://pubmed.ncbi.nlm.nih.gov/36334259/ ·       IMPROVE AD Trial website - https://improvead.org ·       John Ritter Foundation for Aortic Health - https://johnritterfoundation.org ·       Think Aorta US - https://thinkaorta.us   Follow us @audiblebleeding Learn more about us at https://www.audiblebleeding.com/about-1/ and provide us with your feedback with our listener survey.  *Gore is a financial sponsor of this podcast, which has been independently developed by the presenters and does not constitute medical advice from Gore. Always consult the Instructions for Use (IFU) prior to using any medical device.      

Is the future of nasal polyp treatment right under our nose? In this episode of Backtable ENT, Dr. Martin Citardi, a world-renowned rhinologist and skull-based surgeon at UTHealth Houston, discusses the latest advancements in the management of nasal polyps with hosts Dr. Gopi Shah and Dr. Ashley Agan.---This podcast is supported by:Medtronic ENT---SYNPOSISDr. Citardi shares insights from his comprehensive career, spanning patient care, device, and drug development. The surgeons discuss the evolving treatment landscape, challenges in managing recurrent nasal polyps, the role of steroids and biologics, and the importance of correctly identifying the type of polyps. Additionally, Dr. Citardi emphasizes the need for a better understanding of healthcare economics, particularly concerning the high costs of new treatments. The discussion also touches on the future of research and the need for a system to deploy treatment options effectively.---TIMESTAMPS00:00 - Introduction04:39 - Nasal Polyps: Patient Presentation and Initial Examination10:25 - Detailed Examination and Endoscopy Techniques17:26 - Imaging and Lab Workup20:11 - Treatment Strategies and Patient Management31:08 - Managing Patients with Allergies, AERD, and Asthma34:09 - Biologics vs. Surgery: A Comparative Discussion42:50 - Steroid Delivery Methods and Their Effectiveness52:24 - Follow-Up, Long-Term Management and Future Research57:01 - Conclusion and Final Thoughts---RESOURCESDr. Martin Citardi's Profile:https://www.utphysicians.com/provider/martin-j-citardi/Medtronic ENT:https://www.medtronic.com/en-us/healthcare-professionals/products/ear-nose-throat

Listen as benefits expert, Jennifer Figueroa, helps us learn how to prepare and navigate the UT retirement system.Guest: Jennifer FIgueroa, Asst. Director of Benefits

Listen as cardiologist, Dr. Brittany Owen, shares insights on: role of lifestyle and DNA on heart risk factors building a healthy heart types of heart plaque signs/symptoms of a heart attack what you can stop immediately to improve heart healthGuest: Brittany Owen, MD, Interventional and Structural CardiologistAssistant Professor of Medicine, Department of CardiologyMcGovern Medical School at UTHealth Houston

On This Episode We Discuss: In this episode we explore genetic testing in low risk populations, both in direct-to-consumer and clinical settings. We interview authors on two recent JoGC papers related to topics of communication of health risks, understanding of genetic testing, and informed decision-making. You can find the Journal of Genetic Counseling webpage via onlinelibrary.wiley.com or via the National Society of Genetic Counselors website.   Segment 1: An analysis of direct-to-consumer genetic testing portals and their communication of health risk and test limitations Nicole Lee is an associate professor of communication in the School of Social and Behavioral Sciences at Arizona State University. Her research examines the intersection of science communication, public relations, and digital media. This work has been applied to many contexts including climate change, biodiversity research, wellness products, and direct-to-consumer genetic testing. x: @lee_nicole linkedin: https://www.linkedin.com/in/nicoleleepr/   In this segment we discuss: - What motivated the exploration of how direct-to-consumer (DTC) genetic testing companies communicate health risks to consumers. - Potential impacts on consumers who may misinterpret relative risk when presented without adequate context. - Importance of genetic counselors in improving interpretation and communication of DTC genetic test results. - Suggestions for enhancing transparency and clarity in communicating health risks to consumers.   Segment 2: Non-Invasive Prenatal Screening: Testing Motivations and Decision Making in the Low-Risk Population Meagan Choates, MS, CGC is the Assistant Program Director of the University of Texas Genetic Counseling Program and Assistant Professor in the Department of Obstetrics, Gynecology, and Reproductive Sciences at the McGovern Medical School at UTHealth Houston where she practices prenatal genetic counseling. She received a BS in Biochemistry and Genetics with a Minor in Psychology from Texas A&M University in 2014 and an MS in Genetic Counseling from the University of Texas Genetic Counseling Program in 2016. Meagan provides prenatal genetic counseling services at several Houston area clinics, and supervises genetic counseling students while on their prenatal rotation. In addition, she directs and teaches the genetic counseling program's Embryology course and Approaches to Genetic Counseling Research I & II. She co-directs and teaches in the program's Prenatal Genetic Counseling, Psychosocial Issues, and Psychosocial Practicum courses. She additionally oversees the genetic counseling students' Master of Science thesis research process. Her personal research interests include understanding how genetic screening and testing options are discussed, utilized, and interpreted in the clinical setting. ResearchGate profile: https://www.researchgate.net/profile/Meagan-Choates-2 In this segment we discuss: - The anecdotal observations that inspired the study, notably that low-risk and high-risk patients shared similar motivations for choosing NIPT. - That insurance coverage was the second most significant factor influencing the decision to undergo NIPT. - About 44% of participants were classified as making "uninformed decisions" despite receiving pre-test counseling from a genetic counselor. However, the term “uninformed” used by the MMIC tool can be misleading. - The challenge of balancing detailed knowledge expectations with patients' ability to make value-consistent and thoughtful decisions.   Would you like to nominate a JoGC article to be featured in the show? If so, please fill out this nomination submission form here. Multiple entries are encouraged including articles where you, your colleagues, or your friends are authors.   Stay tuned for the next new episode of DNA Dialogues! In the meantime, listen to all our episodes Apple Podcasts, Spotify, streaming on the website, or any other podcast player by searching, “DNA Dialogues”.    For more information about this episode visit dnadialogues.podbean.com, where you can also stream all episodes of the show. Check out the Journal of Genetic Counseling here for articles featured in this episode and others.    Any questions, episode ideas, guest pitches, or comments can be sent into DNADialoguesPodcast@gmail.com.    DNA Dialogues' team includes Jehannine Austin, Naomi Wagner, Khalida Liaquat, Kate Wilson and DNA Today's Kira Dineen. Our logo was designed by Ashlyn Enokian. Our current intern is Sydney Arlen.

In this "Ask the Expert" episode titled, "Women's Health within Neuroimmunology," Dr. Sonia Singh joined Krissy Dilger of SRNA to share women's health concerns within the context of neuroimmunology, focusing on issues like fertility and pregnancy for those with rare neuroimmune disorders [00:01:20]. Dr. Singh discussed how certain conditions, such as neuromyelitis optica spectrum disorder (NMOSD) and autoimmune encephalitis, and medications could impact fertility [00:03:45]. They also explored the increased risks of relapse during and after pregnancy and the importance of coordinated care between neurologists and obstetricians [00:07:10]. Dr. Singh emphasized the importance of teamwork during pregnancy to ensure optimal outcomes for both mother and child [00:21:45]. Sonia Kaur Singh, MD is a Neurologist and Assistant Professor of Neurology at Medical University of South Carolina (MUSC), Charleston who specializes in Neuroimmunology. Dr. Singh obtained her medical degree from Kasturba Medical College, Mangalore in Southern India. After graduation, she worked with dementia specialists in India studying dementia in culturally and linguistically diverse populations. She completed her neurology residency at University of Texas Health Science Center Houston (UTHealth Houston) in the Texas Medical Center. During residency, she was involved with innovative learning strategies including a structural competency curriculum and graduated with the prestigious Frank Yatsu Award for Excellence in Clinical Neurology. After residency, she completed a one-year fellowship in Multiple Sclerosis and Neuroimmunology from UTHealth Houston where she was actively involved in medical education and clinical trials. Dr. Singh has a special interest in women's health and cognition in neuroimmune conditions.

This is the second part in our series discussing temporary mechanical circulatory support (tMCS). Part one, covered different types of devices for tMCS, pathophysiology of shock, clinical indications, and general considerations for critical care clinicians. In Part 2, Dr. Zanotti covers a more detailed discussion of medical management and troubleshooting of patients on tMCS. He is again joined by Bindu Akkanti, MD, an associate professor in the Division of Pulmonary, Critical Care, and Sleep Medicine at UTHealth Houston. Dr. Akkanti is the Medical Director of the Heart Failure ICU and the Director of Critical Care for the Heart & Vascular Institute at Memorial Hermann Texas Medical Center. Additional Resources: More about Dr. Akkanti: https://med.uth.edu/internalmedicine/2022/11/17/bindu-akkanti-md/ Mechanical Circulatory Support Part 1 - Critical Matters Podcast. https://soundphysicians.com/podcast-episode/?podcast_id=342&track_id=1828006629 A Comprehensive Review of Mechanical Circulatory Support Devices. V Atti, et al. Heart Intl. 2022. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9524665/ American Society of Artificial Internal Organs website. https://asaio.org/ IABP: Hemodynamics, troubleshooting, technical tips. https://www.youtube.com/watch?v=ULgjuhBgP9U Composer and Musician A.R. Rahman. https://www.arrahman.com/

In this podcast episode, Taylor Arenz interviews Dr. Rod Jay Turner Jr., a primary care and sports medicine specialist, to explore the intersection of healthcare and sports.Dr. Turner shares his journey, from obtaining a bachelor's in molecular and cellular biology from Vanderbilt University to earning a master's and medical degree from UTHealth Houston. With a rich background of research and residency at UTHealth Houston, Dr. Turner offers a unique perspective on sports medicine.They discuss Dr. Turner's role as the team physician for major sports teams including the Houston Rockets, Houston Dynamo, and St. Thomas University, and delve into the importance of tailored treatment plans for sports-related injuries.The conversation highlights how Dr. Turner balances his clinical commitments with his responsibilities as an assistant professor in the Department of Family and Community Medicine at McGovern Medical School at UTHealth Houston.Dr. Turner also illuminates the latest advancements in sports medicine, preventive measures for athletes of all ages, and a holistic approach to sports-related healthcare. He emphasizes the crucial role of education and continuous learning in effectively managing and treating sports injuries.Tune in to this episode to gain insights into the dynamic field of sports medicine and the passion driving healthcare professionals dedicated to the well-being of athletes.

In the first part of this two-part series, Dr. Zanotti is joined by Bindu Akkanti, MD, an associate professor in the Division of Pulmonary, Critical Care, and Sleep Medicine at UTHealth Houston. Together, they discuss temporary mechanical circulatory support, an increasingly vital modality in treating cardiogenic shock and other subsets of critically ill patients in shock. Dr. Akkanti is the Medical Director of the Heart Failure ICU and the Director of Critical Care for the Heart & Vascular Institute at Memorial Hermann Texas Medical Center. Additional Resources: More about Dr. Bindu Akkanti: https://med.uth.edu/internalmedicine/2022/11/17/bindu-akkanti-md/ Review of Pathophysiology of Cardiogenic Shock and Escalation of Mechanical Circulatory Support Devices. Pahuja M, et al. Curr Cardiol Rep 2023: https://pubmed.ncbi.nlm.nih.gov/36847990/ Temporary mechanical circulatory support devices: practical considerations for all stakeholders. Salter BS, et al. Nature Reviews Cardiology 2023: https://www.nature.com/articles/s41569-022-00796-5 Microaxial Flow Pump or Standard Care in Infarct-Related Cardiogenic Shock. Moller JE, et al. N Engl J Med 2024: https://www.nejm.org/doi/full/10.1056/NEJMoa2312572 Books Mentioned in this Episode: The Alchemist. By Paulo Coelho: https://bit.ly/3yv4Zmt

Fiona Smith, a PhD student at the Cizik School of Nursing at UTHealth Houston and Stroke Coordinator at Houston Methodist Sugar Land Hospital, recently joined the Institute for Stroke and Cerebrovascular Diseases Stroke Busters podcast to discuss her research on stroke awareness within the Spanish-speaking community. Smith's passion for improving stroke care and reducing disparities in healthcare access has driven her to focus on the cultural factors that influence care-seeking behavior among Spanish speakers. Smith highlighted the importance of the RAPIDO acronym, a Spanish-language tool designed to help individuals recognize the signs of stroke and take action. RAPIDO, which translates to "fast" in English, stands for: R: Rostro caído (fallen face) A: Afectación de equilibrio (balance impairment) P: Pérdida de fuerza en los brazos (weakness in the arms) I: Impedimento visual (visual impairment) D: Dificultad para hablar (difficulty speaking) O: Obtener ayuda (obtain help) Smith emphasized that while the RAPIDO acronym is an essential tool for stroke recognition, it is equally important to understand the cultural factors that may influence an individual's decision to seek care. Her current research focuses on identifying these variables and developing strategies to ensure that everyone seeks care as quickly as possible when experiencing stroke symptoms. Smith also stressed the importance of collaboration among healthcare professionals, including nurses, doctors, therapists, and technologists, in making significant changes to improve stroke care in the community. She encourages healthcare professionals and researchers passionate about addressing cultural barriers to find mentors and advisors who can provide guidance and support in pursuing their research goals. Fiona Smith's dedication to improving stroke awareness and care within the Spanish-speaking community serves as an inspiration to healthcare professionals and researchers alike. Her work highlights the importance of understanding and addressing cultural factors in healthcare delivery and the power of community engagement in promoting better health outcomes for all. Stroke Busters, a Podcast Presented by: The Institute for Stroke and Cerebrovascular Disease at the University of Texas Health Science Center at Houston (UTHealth) or “Stroke Institute Genre: Medicine About StrokeBusters is a podcast series of recorded conversations on the topic of stroke and cerebrovascular disease. Based in the Texas Medical Center, the largest medical center in the world, we tap into our local network of astonishing leaders in healthcare and medicine to discuss the latest and most exciting news in stroke. Throughout this ten-episode series, we connect with UTHealth physicians and researchers, many who are experts in their field, to discuss their practice, cutting-edge research and medical care. Who We Are The Institute for Stroke and Cerebrovascular Disease, better known as the Stroke Institute, serves as a multi-disciplinary hub for research and best practices in stroke recovery, stroke prevention, services, population health, and vascular dementia. We are one of the most active research and clinical programs in the country, the first Comprehensive Stroke Center in the state, and launched the first Mobile Stroke Unit in the nation. Our stroke program, founded by Dr. James Grotta in 1979, specializes in stroke epidemiology, clinical trial design, and basic science. We train the next generation of revolutionary academics and leaders in cerebrovascular disease through our NINDS-funded fellowship programs. Contact For more information or if you have any questions, please contact us at info.uthiscd@gmail.com

Welcome to the Stroke Busters Podcast! I'm your host, Amy Quinn, and I'm thrilled to take you on a journey into the fascinating world of stroke research and innovation. Join me as we delve into the latest breakthroughs and insights from the Institute for Stroke and Cerebrovascular Diseases at UTHealth Houston. At the Stroke Busters Podcast, we're on a mission to decode the complexities of strokes, those unexpected disruptions in brain blood flow that can change lives in an instant. Our team of experts, affectionately known as the Stroke Busters, is committed to exploring new frontiers in stroke science, clinical excellence, and public awareness. Each episode will bring you captivating conversations with top physicians, researchers, and courageous survivors, offering valuable perspectives on cutting-edge research, transformative therapies, and inspiring tales of resilience in the face of adversity. Get ready to expand your knowledge and be inspired by the incredible work being done in the world of stroke care. This is the Stroke Busters Podcast, where we break barriers, ignite curiosity, and empower change. Today, we are honored to have with us a distinguished guest who brings over 20 years of invaluable research experience to the field of stroke care. Starting her journey at MD Anderson Cancer Center and Baylor College of Medicine, she has made significant contributions to neurology and stroke research at Texas Oncology and currently at UT Health. A native Houstonian, she not only excels in her professional endeavors but also embraces an active lifestyle. She has conquered numerous marathons, 10k's, and 5k's, showing her determination and resilience. From MUD runs to step aerobics and trampoline classes, she embodies the importance of physical wellness. Beyond her professional and athletic achievements, our guest is deeply committed to community service. She actively participates in health fairs, community outreach programs, and prevention events, demonstrating her dedication to giving back and improving public health. Join me in welcoming our esteemed guest, a passionate researcher, an avid athlete, and a devoted community advocate. Welcome to the show! ____ StrokeBusters, a Podcast Presented by: The Institute for Stroke and Cerebrovascular Disease at the University of Texas Health Science Center at Houston (UTHealth) or “Stroke Institute Genre: Medicine About StrokeBusters is a podcast series of recorded conversations on the topic of stroke and cerebrovascular disease. Based in the Texas Medical Center, the largest medical center in the world, we tap into our local network of astonishing leaders in healthcare and medicine to discuss the latest and most exciting news in stroke. Throughout this ten-episode series, we connect with UTHealth physicians and researchers, many who are experts in their field, to discuss their practice, cutting-edge research and medical care. Who We Are The Institute for Stroke and Cerebrovascular Disease, better known as the Stroke Institute, serves as a multi-disciplinary hub for research and best practices in stroke recovery, stroke prevention, services, population health, and vascular dementia. We are one of the most active research and clinical programs in the country, the first Comprehensive Stroke Center in the state, and launched the first Mobile Stroke Unit in the nation. Our stroke program, founded by Dr. James Grotta in 1979, specializes in stroke epidemiology, clinical trial design, and basic science. We train the next generation of revolutionary academics and leaders in cerebrovascular disease through our NINDS-funded fellowship programs.

Listen as Dr. Chaoul shares insights into the pathways to our life's purpose. Topics: Does everyone have a purpose? Do we seek purpose or does it find us? How do we manifest our purpose? Where does our purpose live? Can our purpose change or evolve? Guest: Alejandro Chaoul, PhD Huffington Foundation Endowed Director The Jung Center's Mind Body Spirit Institute  Adjunct Faculty, McGovern Medical School at UTHealth Houston and MD Anderson Cancer Center

The saying “slow is smooth, and smooth is fast” comes to mind as a theme of today's conversation with Johnson George, MBA, PMP, CAHIM, on the Faculty Factory Podcast. This famous axiom underscores the importance of precision, consistency, and maintaining control as you go about your daily responsibilities and tasks. Relationships and human connection are to be key characteristics for our future leaders, as the frenetic pace of working in academic medicine can often make us feel like we're just robots plowing through to-do lists. We're excited to welcome back Mr. George for today's episode. He currently serves as Assistant Dean - Administration and Faculty Affairs at UTHealth Houston's McGovern Medical School. Congratulations are also in order for Mr. George for being named chair-elect of the AAMC's Group on Faculty Affairs (GFA) Steering Committee, as mentioned in today's broadcast. Overall, Mr. George's takeaway for our community of faculty development and faculty affairs personnel is that the future is bright for our next generation of leadership. Other themes explored in today's conversation include: Intention vs. Impact. “What got you here won't get you there.” Community-building and empathy. Adapting to the changing times as leaders. Navigating generational differences and a multigenerational workforce with emotional intelligence. Catching Up with Johnson George, MBA, PMP, CAHIMS Did you know? This is not his first appearance on the podcast; it's been nearly five years, though, since we heard from him on an episode from 2019 called “Catching up with Johnson George, MBA, PMP, CAHIMS.” Johnson brings an information technology background and thus an engineering-type mindset to his various roles in academic faculty affairs. Alongside leading with empathy, his unique background was a theme we explored in-depth on our podcast the first time Mr. George joined us. You can explore that episode here: https://facultyfactory.org/catching-up-with-johnson-george-mba-pmp-cahims/ You can also contact him here: Johnson.george@uth.tmc.edu

Welcome back to Stroke Busters where we bring you groundbreaking research and expert insights from the Institute for Stroke and Cerebrovascular Diseases at UTHealth Houston. Our team is committed to unraveling the mysteries surrounding strokes, those unexpected interruptions to the blood flow in the brain that can have life-altering consequences. Our team of experts, or as we like to call them Stroke Busters, is dedicated to pushing the boundaries of stroke research, clinical care, and public awareness. Each episode of the Stroke Busters Podcast will feature engaging conversations with leading physicians, researchers, and survivors, providing valuable insights into the latest advancements in stroke science, innovative treatments, and inspiring stories of triumph over adversity. Today, we were honored to chat with our special guest, a true luminary in the world of neurology and health disparities research. Dr. Lewis Morgenstern, a Professor of Neurology, Epidemiology, Emergency Medicine, and Neurosurgery at the University of Michigan Medical School and School of Public Health. Dr. Morgenstern has been at the forefront of groundbreaking research, serving as the Principal Investigator of the NIH-funded Brain Attack Surveillance in Corpus Christi (BASIC) project since 1999. With over 130 original, peer-reviewed manuscripts under his belt, his expertise spans health services clinical trials, stroke epidemiology, and clinical studies of intracerebral hemorrhage. We were able to ask Dr. Morgerstern a few more questions following his Grand Rounds presentation for medical students and faculty at the McGovern Medical School in Houston, TX,  with our host, Dr. Carlos De Garza. ______ StrokeBusters, a Podcast  Presented by: The Institute for Stroke and Cerebrovascular Disease at the University of Texas Health Science Center at Houston (UTHealth) or “Stroke Institute  Genre: Medicine    About  StrokeBusters is a podcast series of recorded conversations on the topic of stroke and cerebrovascular disease. Based in the Texas Medical Center, the largest medical center in the world, we tap into our local network of astonishing leaders in healthcare and medicine to discuss the latest and most exciting news in stroke. Throughout this ten-episode series, we connect with UTHealth physicians and researchers, many who are experts in their field, to discuss their practice, cutting-edge research and medical care.  Who We Are  The Institute for Stroke and Cerebrovascular Disease, better known as the Stroke Institute, serves as a multi-disciplinary hub for research and best practices in stroke recovery, stroke prevention, services, population health, and vascular dementia. We are one of the most active research and clinical programs in the country, the first Comprehensive Stroke Center in the state, and launched the first Mobile Stroke Unit in the nation.  Our stroke program, founded by Dr. James Grotta in 1979, specializes in stroke epidemiology, clinical trial design, and basic science. We train the next generation of revolutionary academics and leaders in cerebrovascular disease through our NINDS-funded fellowship programs.  Our Podcast Audience  Our podcast content is targeted to stroke trainees (fellows, residents, medical students); however, we receive a wide range of listeners primarily in their 20's to 40's with moderate to advanced levels of education.  Contact  For more information or if you have any questions, please contact us at info.uthiscd@gmail.com 

Listen as Dr. Majid shares her insights as a sleep expert regarding: Naps Insomnia Sleep debt Restorative sleep Circadian Rhythm Sleep and weight gain Optimal sleep environments How many hours do I really need? ...and more! Guest: Dr. Ruckshanda Majid Department of Pulmonary, Critical Care, and Sleep Medicine McGovern Medical School at UTHealth Houston

From the Institute for Stroke and Cerebrovascular Diseases at UTHealth Houston, today, we delve into a fascinating study exploring the intriguing concept known as the "obesity paradox" in patients with spontaneous intracerebral hemorrhage (ICH). Joining us are two esteemed guests, Dr. Jared Chen and Dr. Andrea Gaitan, who played integral roles in this research.  You are in for a treat as we unpack the study's background, objectives, and compelling results. The study, aiming to understand the association between body mass index (BMI) and functional outcomes in patients with ICH, also explores the role of race/ethnicity in this relationship. Their research article can be found at https://www.neurology.org/doi/10.1212/WNL.0000000000208014

Guest: J. William Lindsey Epstein-Barr virus (EBV) has long been associated with multiple sclerosis (MS), but a recent study from UTHealth Houston has shed light on its role in the development of MS. To learn more on what we know about EBV-specific T-cells, join Dr. J. William Lindsey, Senior Author of the study, titled UTHealth Houston Study: EBV-specific T-cells play key role in development of multiple sclerosis, and Professor in the Department of Neurology and Director of the Division of Multiple Sclerosis and Neuroimmunology with McGovern Medical School at UTHealth Houston.

Gun violence in the United States—the country with the highest gun ownership per capita—is an entrenched public health issue that impacts Americans across demographics and geographies. According to the Centers for Disease Control & Prevention, 327 people a day are shot in the US, and 42,654 die from gun violence each year. Since the 1990s, Texas firearm-related homicides rose 66% and suicides involving firearms rose 40%. The Austin American-Statesman stated that Texas topped the list of gun related deaths in 2021, and in 2022 we witnessed the catastrophic mass-shooting in Uvalde leaving 19 children and two teachers dead at an elementary school. In the spirit of Dr. King's commitment to address critically important justice issues and create a more equitable society through engaging in nonviolent tactics, this event provides space to learn more about the public health impacts of gun violence, and to delve into our collective responsibilities to address this critical epidemic. The event will feature keynote speaker David Hogg, Co-Founder of March For Our Lives, followed by a panel of local public health researchers and organizers including Dr. Jeff Temple, Dean of Clinical Research in the School of Behavioral Health Science at UTHealth Houston; Dr. Bindi Naik-Mathuria, Pediatric Trauma Surgeon at UTMB; Karlton Harris, Executive Director of The Forgotten Third; and Kimberly Mata-Rubio, who recently ran for mayor of Uvalde after her daughter was killed in the Robb Elementary School Shooting. The program featured a temporary memorial installation on the Plaza by Sandeigh Kennedy exploring the impacts of gun violence in 2023, contemplative music by DACAMERA Young Artists and poetry by Texas Poet Laureate Lupe Mendez. Local organizations addressed gun violence in Houston and Texas were onsite after the event to share information about how to get involved in gun violence prevention efforts. About the Annual MLK Birthday Observance In 1979, The Rothko Chapel started the annual MLK Birthday Observance to connect the contemporary implications of Rev. Dr. Martin Luther King Jr.'s legacy to the ongoing struggle for civil and human rights, captured through artist Barnett Newman's Broken Obelisk. This sculpture, located on the plaza adjacent to the Chapel, is dedicated to Dr. King. Recent presenters have included Civil Rights Freedom Singer Rutha Mae Harris, artist David Banner, columnist Leonard Pitts, Jr., environmental justice leader Dr. Robert Bullard, MacArthur Fellow Dr. Keeanga-Yamahtta Taylor, the Scott Joplin Chamber Orchestra, and photographer Devin Allen.

“With the turnover rates where they're at now, there's no way we can keep thinking how we did in the past—like, we have to. There's no doubt. We have to think differently,” Deborah Cline, DNP, RN, associate professor in the Department of Graduate Studies with Cizik School of Nursing at UTHealth Houston in Texas, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a discussion about oncology nurse retention.  You can earn free NCPD contact hours after listening to this episode and completing the evaluation linked below.   Music Credit: “Fireflies and Stardust” by Kevin MacLeod  Licensed under Creative Commons by Attribution 3.0  Earn 1.0 contact hours of nursing continuing professional development (NCPD), which may be applied to the professional practice and performance ILNA categories, by listening to the full recording and completing an evaluation at myoutcomes.ons.org by December 29, 2025. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of NCPD by the American Nurses Credentialing Center's Commission on Accreditation.  Learning outcome: The learner will report an increase in knowledge related to nurse retention strategies.  Episode Notes  Complete this evaluation for free NCPD.  Oncology Nursing Podcast: Episode 231: Nurses Thrive in a Healthy Work Culture Episode 187: The Critical Need for Well-Being and Resiliency and How to Practice Episode 85: Nursing Resilience and Self-Care Aren't Optional  ONS Voice articles: Train and Retain: From Orientation to Leadership, Here Are the Strategies That Experienced Staff Developers Use American Rescue Plan Funds Will Reduce Burnout, Promote Mental Wellness Among Healthcare Workforce Biden-Harris Administration Invests $100 Million in Awards to Grow the Nursing Workforce Create Space Between Work and Life With These ONS Member-Tested Techniques  Clinical Oncology Nursing: Will You Leave or Stay?  ONS Nurse Well-Being Learning Library  ONS Symptom Interventions and Guidelines: Peripheral Neuropathy  The Journal of Excellence in Nursing Leadership: The Accreditation in Shared Governance Program (Robert Hess)  American Nurses Foundation Stress and Burnout Prevention Program  National Academy of Medicine Action Collaborative on Clinician Well-Being and Resilience  Would you like to hear more from Debbie and about the future of nurse retention? Check out her next presentation at ONS Congress® in April 2024.  To discuss the information in this episode with other oncology nurses, visit the ONS Communities.   To find resources for creating an ONS Podcast Club in your chapter or nursing community, visit the ONS Podcast Library.  To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org.  Highlights From Today's Episode  “When you look at the data, we have over 3 million nurses in the United States. Approximately, 1.7 million of those are in the hospitals, but unfortunately, the turnover rate has nearly doubled. Just since 2019, where it was about 15.9% nationally, we are over 27% since 2021.” TS 1:45  “The data actually shows that it's turnover in early-career nurses. When we're looking at that first five years of data and who's turning over, it's our nurses that are one to two years. Our patients are so complex. When you're looking at staff turnover that's early, we're going to have a huge problem getting to the point where we can keep some of the knowledge going, and when you lose them early, it's not good for nursing and oncology nursing in specific.” TS 3:05  “In May of this year, we learned that nursing enrollments for entry level baccalaureate programs are down for the first time in over a 20-year period. So, that is really concerning. So, enrollments are down. There's challenges getting clinical placements depending on where you are, not to mention that oncology clinical placements I think are even harder to come by. Some organizations feel very strongly that clinical placement in an oncology setting may not be appropriate for undergraduate students.” TS 6:06  “A lot of children don't understand what it is that a nurse does. When you ask them, ‘Oh, you give shots,' and that's your role. And so really helping kids at all ages—elementary, middle school, high school—talking to them about what nursing is, what it looks like on a day-to-day basis, the critical skills you need to the complexity of your workday, I think can really incite some younger children to understand, ‘Oh, nursing is an option for me.'” TS 8:47  “It's a challenge to put your head around. I could be a new grad doing this, and we all have this, you know, idealism that, ‘Oh, you have to have acute care inpatient first before you can do that,' but we can't, right? We can't sustain that model. So, how are we building our programs to ensure that ambulatory care nurses that happen to be new grads in oncology are getting a solid training program with stable preceptorship and a very structured program that can be individualized to their needs?” TS 14:12  “There's also the aging workforce. The oncology nurses that have started in oncology or transition to oncology at any point in time—they love it. … Anecdotally, we probably have some of the most experienced nurses in many of our organizations that are in oncology. Those nurses are also looking at retiring.” TS 17:38  “You have to have professional development opportunities. What educational opportunities? And if your organization doesn't have the funding for that, that's okay. You could promote education that might be free online or through Oncology Nursing Society. There are ways to bring your staff education that doesn't cost a lot of money, but many organizations do have an education team that may also be adding to those opportunities.” TS 20:13  “If you're in a unit that has a lot of vacancy rates, how often are you sharing with nursing staff, ‘Okay, I've done X amount of interviews this week, or we have these new nurses coming in to join us or nursing assistants, whatever role that may be coming to join us.'  What does that timeline look like? A lot of times I think we don't promote that transparency well enough. And I think establishing that communication with your team and increasing the level of trust and transparency is so vital.” TS 26:12  “My first organization to my second organization, I was still a stem cell transplant nurse, but the experience was different. So, we need to also trust ourselves that sometimes it's just not the right fit. And I don't think we do a good job as nursing organization and like as health care organizations supporting those types of transitions. And I think there's a lot of opportunity there.” TS 32:25  “Ensuring that you're not picking up so much overtime, you don't have time—the downtime to take care of yourself and take care of your family and spend time and figure out what feeds your soul. I think it's so, so important to figure out what that is for yourself. And sometimes it takes a lot of reflection and exploration to figure that out. But it's worth the time in the effort to do that.” TS 41:06  “A lot of times, it's easy to kind of get in this, ‘I'm just going to keep complaining, but I'm not going to do anything.' But we all need to be part of the solution to get us moving forward and to stabilize the nursing shortages that we have. And unfortunately, I don't think it's going away. I think we've got several more years that we're all going to have to purposely look for solutions and work on implementing solutions to help stabilize the workforce.” TS 44:27  “Your best resource, and I say it again, is your team, your team, your team, your team. Talk to each other. Help figure out solutions together that are going to work for your specific milieu.” TS 49:14 

The Future of Cardiac Monitoring and Anticoagulation After Ischemic Stroke and TIA w/ Luciano A. Sposato, MD MBA FRCPC Professor of Neurology, Western University Host: Jacob Sambursky, MD Welcome back to Stroke Busters, a podcast presented by the Institute for Stroke and Cerebrovascular Disease at UTHealth Houston. On this show, we connect with leaders in stroke care, research, community, and academia. We're not just active; we're at the forefront—recognized as the first Comprehensive Stroke Center in the state and pioneers in launching the nation's first Mobile Stroke Unit. I'm Amy Quinn, Communications Director for the Stroke Institute, and proud to bring you another episode to share expert insights, groundbreaking research, and real stories from the forefront of medicine.  It's that time again for a Grand Rounds follow-up interview! Dr. Luciano Sposato, Professor of Neurology, at Western University joined us for Grand Rounds at the McGovern Medical School here in Houston, TX, and presented on The Future of Cardiac Monitoring and Anticoagulation After Ischemic Stroke and TIA.  Following his Grand Rounds presentation for trainees and students, one of our Stroke Fellows Jacob Sambursky, stuck around to ask some more in-depth questions. As always, Ideas and opinions expressed on this podcast are our own and are not a substitute for expert medical advice. Always contact your doctor before starting any program or therapy to make sure you are getting the best care, tailored to your unique situation.   UTHealth Stroke is on social media! Follow us on Twitter, LinkedIn, Instagram, and Facebook at UTHEALTHSTROKE to stay updated on upcoming episodes, and share with colleagues, friends, and family.  For updates and the latest news on the Stroke Institute, go online to uth.edu/stroke-institute

Welcome to another episode of the Stroke Busters Podcast, your go-to source for all things related to stroke, research, community, and academia. Today's episode is part 2 of our Yatsu Day Series, bringing you an inside peek at the speakers who will be presenting at the 14th Annual Yatsu Day Symposium, presented by the Stroke Institute, here in Houston, TX on November 10, 2023.  The theme for the 2023 symposium is “Nurturing Brain Health and Preventing Stroke” The event will help increase physicians' and trainees' knowledge in lifestyle modifications, mental well-being, and brain health education for patients. Topics include nurturing brain health, preventing stroke and dementia, risk predictions for stroke, identifying stroke risk using artificial intelligence, cognitive testing, sleep and brain health, and more. This program is accredited for CME and CNEs, catering to a diverse spectrum of healthcare professionals. It is designed to benefit physicians, nurses, occupational therapists, physical therapists, speech-language pathologists, and other healthcare providers who work closely with individuals affected by stroke and dementia. Additionally, it is valuable for those who have an interest in brain health, health promotion, and stroke prevention. Local speakers and interactive sessions leaders from UTHealth-Houston and Memorial Hermann include James Grotta, MD Myriam Fornage PhD, Xiaoqian Jiang, PhD, Anjail Z. Sharrief, MD, MPH, Heather Smith MA, CCC-SLP, CBIS, Kendra M. Anderson, PhD, and Seema Aggarwal, APRN, PhD. And you can also anticipate insights from globally recognized experts in the field of stroke care; ⁠Vladimir Hachinski, MD, DSc (see part 1 of this Yatsu Day series) Today's guest is Dr. Kendra Anderson who will be presenting at an interactive station at this year's Yatsu Day Symposium. She will explore the benefits of neuropsychological evaluation following stroke and how a neuropsychologist can be an ally for stroke practitioners to provide patient-centered care. Dr. Anderson will also include the segment “Ask a Neuropsychologist,” during which practitioners can ask any questions about the services we provide. There will also be demonstrations of the types of activities we do with patients. Learn more about Yatsu Day at uth.edu/stroke-institute/events/yatsu-day

Listen as Dolores Woods shares her insights on putting our relationships with people first, as a way to manage our nutrition during the holiday season. The podcast also includes a discussion about comfort food, tips for recipe substitutions, and choices related to desserts and beverages. Dolores is a Nutritionist Supervisor for the Nourish Program at the Michael and Susan Dell Center for Healthy Living at UTHealth Houston's School of Public Health.

Dr. Paul Schulz, Professor of Neurology and Director of the Neurocognitive Disorders Center at the McGovern Medical School at UTHealth Houston, explains the findings of recent research on Newsline with Brigitte Quinn.

Plague and anthrax are feared diseases due to high mortality rates following pulmonary exposure, and both are considered potential bioweapons.  Dr. Virginia Miller, professor at the University of North Carolina at Chapel Hill and ASM President, studies plague, as well as other Gram negative bacteria. Dr. Theresa Koehler, emeritus professor at UTHealth Houston and ASM president-elect, is an expert in anthrax.  microTalk caught up with Dr. Miller and Dr. Koehler at ASM Microbe 2023 in Houston to discuss these biothreat agents. Dr. Miller discusses why she studies plague, the differences between bubonic and pneumonic plague, why Klebsiella pneumoniae poses a growing health threat, and what it was like being John Mekalanos' first Ph.D. student. Dr. Koehler discusses why anthrax is considered a potential bioweapon, why significant scientific progress was made following the anthrax attacks of 2001, why gardeners shouldn't worry about catching anthrax, and her first failed experiment.  Both discuss their vision for ASM and the role it plays in microbiological research and society. Participants: Karl Klose, Ph.D. (UTSA) Virginia Miller, Ph.D. (UNC Chapel Hill) Theresa Koehler, Ph.D. (UT Health Houston) Janakiram Seshu, Ph.D. (UTSA) Jesus Romo, Ph.D. (UTSA)

Welcome to another episode of the Stroke Busters Podcast, your go-to source for all things related to stroke, research, community, and academia. I'm your host, Amy Quinn, Communications Director for the UTHealth Houston  Institute for Stroke and Cerebrovascular Disease. Today's episode is part 1 of our Yatsu Day Series, bringing you an inside peek at the speakers who will be presenting at the 14th Annual Yatsu Day Symposium, presented by the Stroke Institute, here in Houston, TX on November 10, 2023.  The theme for the 2023 symposium is “Nurturing Brain Health and Preventing Stroke” The event will help increase physicians' and trainees' knowledge in lifestyle modifications, mental well-being, and brain health education for patients. Topics include nurturing brain health, preventing stroke and dementia, risk predictions for stroke, identifying stroke risk using artificial intelligence, cognitive testing, sleep and brain health, and more.  This program is accredited for CME and CNEs, catering to a diverse spectrum of healthcare professionals. It is designed to benefit physicians, nurses, occupational therapists, physical therapists, speech-language pathologists, and other healthcare providers who work closely with individuals affected by stroke and dementia. Additionally, it is valuable for those who have an interest in brain health, health promotion, and stroke prevention. Local speakers and interactive sessions leaders from UTHealth-Houston and Memorial Hermann include James Grotta, MD Myriam Fornage PhD, Xiaoqian Jiang, PhD, Anjail Z. Sharrief, MD, MPH, Heather Smith MA, CCC-SLP, CBIS, Kendra M. Anderson, PhD, and Seema Aggarwal, APRN, PhD. And you can also anticipate insights from globally recognized experts in the field of stroke care; Vladimir Hachinski, MD, DSc, who will be our guest for today's show! He is an eminent figure in the world of cerebrovascular diseases and stroke research, with over five decades of experience and a treasure trove of knowledge, we are thrilled to have him on the show. As an added bonus, Dr. James Grotta, whom we have met many times before, was gracious enough to sit with us to ask Dr. Hachinski some questions about his involvement in Yatsu Day.  So let's get to it! Enjoy, and if you are interested in attending Yatsu Day, visit uth.edu/stroke-institute/events/yatsu-day _____ Dr. Vladimir Hachinski is a distinguished scientist, renowned for his groundbreaking contributions in the field of cerebrovascular diseases and stroke research. One of Dr. Hachinski's most remarkable achievements was co-founding the world's first successful acute stroke unit, which has since become the gold standard of care for stroke patients. Notably, Dr. Hachinski is the author, co-author, or editor of 17 books, including "Stroke: A Comprehensive Guide to Brain Attack," co-authored with his daughter, Larissa Hachinski. Currently, Dr. Hachinski is spearheading the Dementia Prevention Initiative: Advancing Population Prevention Solutions (APPS). This initiative aims to uncover the factors that contribute to the prevention of certain dementias. Dr. Hachinski's research has demonstrated a 32% reduction in stroke incidence and a 7% decline in dementia occurrence due to the successful implementation of an Ontario Stroke Strategy. His work highlights the interconnectedness of stroke, heart disease, and dementia, sharing common risk and protective factors. Dr. Hachinski's accolades include prestigious awards such as the Potamkin Prize for Research in Pick's, Alzheimer's, and Related Diseases, the World Federation of Neurology Medal for Services to World Neurology, the American Academy of Neurology Wartenberg Lecture & Award, and many others. His unwavering commitment to advancing brain health, preventing stroke and dementia, and reshaping the field of cerebrovascular research continues to inspire the medical community and offer hope to individuals affected by these conditions.

Where medical students do their residency is one of the biggest decisions they will make. Knowing what program is right for them can be a challenge. Hilary Fairbrother, MD, MPH, vice chair of education at UTHealth Houston, McGovern Medical School, joins to share best practices on how to search for residency programs and find the best fit. American Medical Association CXO Todd Unger hosts.

Listen as Claire Goss shares insights on the unprecedented challenges facing professional parents today as they manage the interface between work and life. Claire offers tangible tools for dealing with the stress and guilt associated with being a working parent. She discusses concepts such as "bringing the weather" to your household and "firing yourself" by delegating, redirecting, and deploying resources. Claire is the Senior Manager for Parenting Education and Resources at Bright Horizons, a service that provides family caregiver solutions for families of UTHealth Houston. This benefit includes 10 days of emergency/backup child or adult-dependent care provided by Bright Horizons and the employee pays a nominal copay, while UTHealth Houston subsidizes part of the cost of those 10 days. Our contract with Bright Horizons also offers a network of family solutions on a self-pay basis and the subscription to this network is already paid on behalf of employees through the UTHealth Houston contract with Bright Horizons.

Listen as Dr. Higgins shares his insights on ways to work aerobic activity into everyday life. He also shares tips and cautions for training for the Houston Half Marathon/10K race, sponsored by UTHealth Houston on Oct 29. Dr. Higgins is Professor of Medicine at The McGovern Medical School and the Senior Cardiologist at Lyndon B. Johnson General Hospital, among many other accomplishments.

This heat isn't going anywhere, so host Raheel Ramzanali is bringing on Dr. Wafi Momin, cardiologist at UTHealth Houston and Memorial Hermann Katy Hospital, to talk about which groups of people are most at-risk to suffer from heat exhaustion, what you can do to prevent heat related emergencies, and why it's important to know the difference between heat exhaustion and heat stroke.  Dr. Wafi Momin Looking for more Houston news? Then sign up for our morning newsletter Hey Houston  Follow us on Instagram  Have feedback or a show idea? Let us know! or leave us a voicemail/text us at +1 713-489-6972 with your thoughts, we love hearing from you! Interested in advertising with City Cast? Let's Talk! Learn more about your ad choices. Visit megaphone.fm/adchoices

Welcome to this special episode of the NeurologyLive® Mind Moments® podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice. For major FDA decisions in the field of neurology, we release short special episodes to offer a snapshot of the news, including the main takeaways for the clinical community, as well as highlights of the efficacy and safety profile of the agent in question. In this episode, we're covering the recent expanded indication of valbenazine (Ingrezza; Neurocrine Biosciences) to include the treatment of chorea associated with Huntington disease (HD). Erin Furr-Stimming, MD, FAAN, FANA, a professor of neurology at McGovern Medical School of UTHealth Houston, and principal investigator of the phase 3 KINECT-HD studies, valbenazine's supportive studies, offered her immediate reaction to the news. In addition, she spoke about the efficacy observed in these trials, the advantages valbenazine has as a VMAT2 inhibitor, and the remaining unmet needs in the management of HD.   For more of NeurologyLive®'s coverage of valbenazine's expanded indication, head here: FDA Approves Neurocrine Biosciences' Valbenazine for Huntington Disease Chorea Episode Breakdown: 0:30 – Valbenazine approved for Huntington disease chorea 1:35 – Erin Furr-Stimming, MD, FAAN, FANA, on immediate reaction 2:15 – Treatment toolbox for HD chorea  3:05 – Furr-Stimming on mechanistic advantages of valbenazine 5:10 – Phase 3 efficacy data of valbenazine 5:55 – Furr-Stimming on greatest clinical takeaways from trials 6:55 – Current state of Huntington management 8:00 – Furr-Stimming on current unmet needs for patients, including research on disease-modifying therapies Thanks for listening to the NeurologyLive® Mind Moments® podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com. REFERENCES 1. Neurocrine Biosciences Announces FDA Approval of INGREZZA® (valbenazine) Capsules for the Treatment of Chorea Associated With Huntington's Disease. News Release. Neurocrine Biosciences. Published August 18, 2023. Accessed August 21, 2023.

COVID cases in Texas rise by almost 25% in a week as concerns mount over a new variant. Although the vast majority of Texans have given up masks and social distancing, health officials say they’re still important tools as cases pick up and students return to the classroom. Dr. Catherine Troisi of UTHealth Houston joins […] The post Tours from Beyoncé and Taylor Swift are big for local economies appeared first on KUT & KUTX Studios -- Podcasts.

People who are regular cannabis users are at an increased risk of experiencing complications  after surgery, according to a study by researchers with UTHealth Houston. The study was published in a recent issue of JAMA Surgery. Joining me to talk about cannabis use disorder and the findings of the study is Paul Potnuru, MD. Dr Potnuru is the assistant professor in the Department of Anesthesiology, Critical Care and Pain Medicine at McGovern Medical School at UTHealth Houston and the first author of the study.

Summer vacation is upon us and many Americans will be traveling domestically and internationally. Travel can unfortunately also be linked to infectious diseases. My guest today warns the public of five infectious diseases to keep an eye on during summer travel. Joining me on the show is Luis Ostrosky, MD. Dr. Ostrosky is a professor of medicine and epidemiology and chief of infectious diseases at UTHealth Houston.  

Stroke Busters is a podcast presented by the Institute for Stroke and Cerebrovascular Disease at UTHealth Houston in Houston, TX. The purpose of this podcast is to bring you the latest news and discussion in stroke care, research, community, and academia. Today's guest is Dr. Patrick Key, a non-invasive board-certified clinical cardiologist with clinical interests in clinical lipidology, preventive cardiology and non-invasive cardiovascular imaging. His Ph.D. research focuses on the metabolism of high-density lipoproteins (aka good cholesterol). He has an active research program in molecular imaging of atherosclerosis and targeted drug delivery using novel nanoparticles and intravascular devices. He is a member of the National Lipid Association and is up to date with the contemporary management of various lipid disorders. He runs a Level 2 Lipid Clinic and Preventive Cardiology Clinic at the UT Professional Building.  Dr. Kee joined us for Stroke Grand Rounds and stuck around to record this episode with one of our Vascular Neurology Fellows, Jerome Jeevarajan to answer some more questions, so that we can share more of his insight and research. ____________________________________ Twitter: @UTHealthStroke Instagram: @UTHealthStroke Facebook: facebook.com/uthealthstroke LinkedIn: linkedin.com/company/uthealth-stroke Ideas and opinions are our own and this podcast is not a substitute for expert medical advice. About StrokeBusters is a podcast series of recorded conversations on the topic of stroke and cerebrovascular disease. Based in the Texas Medical Center, the largest medical center in the world, we tap into our local network of astonishing leaders in healthcare and medicine to discuss the latest and most exciting news on stroke. Throughout this ten-episode series, we connect with UTHealth physicians and researchers, many of who are experts in their field, to discuss their practice, cutting-edge research, and medical care. Who We Are The Institute for Stroke and Cerebrovascular Disease, better known as the Stroke Institute, serves as a multi-disciplinary hub for research and best practices in stroke recovery, stroke prevention, services, population health, and vascular dementia. We are one of the most active research and clinical programs in the country, the first Comprehensive Stroke Center in the state, and launched the first Mobile Stroke Unit in the nation. Our stroke program, founded by Dr. James Grotta in 1979, specializes in stroke epidemiology, clinical trial design, and basic science. We train the next generation of revolutionary academics and leaders in cerebrovascular disease through our NINDS-funded fellowship programs. Contact For more information or if you have any questions, please contact us at info.uthiscd@gmail.com

What do Magic Johnson, the McGovern Medical School at UTHealth Houston, and a molecule have in common? They each played an unexpected role in changing the course of our next guest, Stanley Lewis, CEO and founder of San Diego-based A28 Therapeutics, on his path toward finding a novel treatment for cancer and advocating for patient diversity in clinical trials. On this episode of LifeLines, Stanley speaks about his journey from academia to blazing his own trail in biotech and founding his own company. As a physician, Stanley specialized in treating HIV patients and helped lead the development of a new HIV drug for a large company. This got the attention of Magic Johnson's doctor, who recruited him to join Tai Med Biologics. Stanley never imagined he would one day be a biotech founder: an interview for a CMO position at a company that was retooling a molecule to treat cancer led him to San Diego. This meeting resulted in him purchasing the rights to the asset instead, establishing A28 Therapeutics. Stanley says it was “off to the races” from that point. “There's really no blueprint for what you're about to undertake. This is not for the faint of heart.” A28 Therapeutics developed a targeted oncolytic peptide platform to treat multiple types of cancers, including ovarian cancer and hepatocellular carcinoma. A28 Therapeutics' lead compound, AT-101—which is in its Phase 2 clinical trial—could potentially kill cancer cells much like how a vaccine treats infectious diseases, Stanley says. The company's goal is to find a treatment for cancer that doesn't cause the side effects often experienced with chemotherapy. Stanley is also passionate about advocating for patient diversity in clinical trials, and he shares the news about a nonprofit he co-founded, CARER, that monitors data on patient enrollment in clinical trials. CARER was born from an idea shared by a colleague who attended Biocom California's inaugural Black Biotech Trailblazers panel, where Stanley was a guest speaker. She approached him after the event, and their discussion on addressing diversity issues in the life science industry led to the creation of the nonprofit. You can follow Stanley Lewis and A28 Therapeutics on LinkedIn. LifeLines is produced by Biocom California, the leader and advocate for life science in California and beyond. To learn more about us, visit biocom.org or engage with us on Twitter and LinkedIn. For a transcript of this episode, you can download it here. Interested in becoming a member or joining us on this podcast? Email podcast@biocom.org. Host: Bob McGriffExecutive Producer: Marie TutkoSenior Producer: Vincenzo TarantinoAssociate Producer: Lauren PanettaProgram & Research Coordinator: Katy BurgessTranscripts By: Jessica Schneider Senior Director of Marketing: Heather RamsayGraphic Design By: Raquel Papike

Cuando una persona abre un libro y comienza a leer, se activan dos redes distintas en el cerebro, que trabajan juntas para integrar los significados de las palabras individuales para obtener un significado más complejo y de orden superior, según revela un estudio llevado a cabo por científicos de la UTHealth Houston y que recoge la revista Proceedings of the National Academy of Sciences (PNAS). ¿Cómo funciona nuestro cerebro?"Nuestros cerebros están notablemente interconectados, y para que entendamos el lenguaje se requiere una secuencia precisa de procesos rápidos y dinámicos que ocurran en múltiples sitios en todo nuestro cerebro", afirman los expertos del estudio.Suscríbete a MUY HISTORIA con un descuento del 50% usando el código especial para podcast - PODCAST1936https://bit.ly/3Mz0ImVComparte nuestro podcast en tus redes sociales, puedes realizar una valoración de 5 estrellas en Apple Podcast o Spotify.Dirección, locución y producción: Iván Patxi Gómez GallegoContacto de publicidad en podcast: podcast@zinetmedia.esSuscríbete a Muy Interesante https://suscripciones.zinetmedia.es/mz/

Cuando una persona abre un libro y comienza a leer, se activan dos redes distintas en el cerebro, que trabajan juntas para integrar los significados de las palabras individuales para obtener un significado más complejo y de orden superior, según revela un estudio llevado a cabo por científicos de la UTHealth Houston y que recoge la revista Proceedings of the National Academy of Sciences (PNAS). ¿Cómo funciona nuestro cerebro? "Nuestros cerebros están notablemente interconectados, y para que entendamos el lenguaje se requiere una secuencia precisa de procesos rápidos y dinámicos que ocurran en múltiples sitios en todo nuestro cerebro", afirman los expertos del estudio. Suscríbete a MUY HISTORIA con un descuento del 50% usando el código especial para podcast - PODCAST1936 https://bit.ly/3Mz0ImV Comparte nuestro podcast en tus redes sociales, puedes realizar una valoración de 5 estrellas en Apple Podcast o Spotify. Dirección, locución y producción: Iván Patxi Gómez Gallego Contacto de publicidad en podcast: podcast@zinetmedia.es Suscríbete a Muy Interesante https://suscripciones.zinetmedia.es/mz/

Harris County and UTHealth Houston have made great strides when it comes to providing mental health help for Houstonians through their partnership, but there's still not enough workers in the field to help those in need. Could a new school help solve that problem? Joining us today is Jair C. Soares, MD, PhD, Professor and Chairman of Psychiatry and Behavioral Sciences at The University of Texas Health Science Center at Houston. Learn more about the new school being approved here! Our morning newsletter Hey Houston brings updates on local news to you daily. Sign up here. Make sure you stay connected to us by following us on Twitter and Instagram @CityCastHouston Or leave us a voicemail/text us at +1 713-489-6972 with your thoughts! We love hearing from you!  Have feedback or a show idea? Let us know!  Interested in advertising with City Cast? Let's Talk! Learn more about your ad choices. Visit megaphone.fm/adchoices

Why Do Humans Anthropomorphize AI? Artificial intelligence has become more sophisticated in a short period of time. Even though we may understand that when ChatGPT spits out a response, there's no human behind the screen, we can't help but anthropomorphize—imagining that the AI has a personality, thoughts, or feelings. How exactly should we understand the bond between humans and artificial intelligence? Guest host Sophie Bushwick talks to Dr. David Gunkel, professor of media studies at Northern Illinois University, to explore the ways in which humans and artificial intelligence form emotional connections.   A Bee's Eye View Of Cities' Microbiomes When you want to look at the microbial health of a city, there are a variety of ways to go about it. You might look at medical records, or air quality. In recent years, samples of wastewater have been used to track COVID outbreaks. Studies of urban subway systems have involved painstaking swabs of patches of subway muck. But now, researchers are offering another approach to sample a city's environment—its beehives. A report recently published in the journal Environmental Microbiome used the bees foraging in a city to provide information about the town's bacteria and fungi. The researchers found that by looking at the debris in the bottom of a beehive, they could learn about some of the environments in the blocks around the hives. The microbes they collected weren't just species associated with flowers and plant life, but included organisms associated with ponds and dogs. The team found that the hive samples could reveal changes from one neighborhood to another in a city, and in the microbial differences between different cities—samples taken in Venice, for instance, contained signals associated with rotting wood that were not seen in samples from Tokyo. Elizabeth Henaff, an assistant professor in the NYU Tandon School of Engineering at New York University and a co-author of the report, joins SciFri's Kathleen Davis to talk about what bees and microbes can tell us about the cities we share.   This Is Your Brain On Words What happens after you pick up a book, or pull up some text on your phone? What occurs between the written words hitting your eyes and your brain understanding what they represent? Scientists are trying to better understand how the brain processes written information—and how a primate brain that evolved to make sense of twisty branches and forking streams adapted to comprehend a written alphabet. Researchers used electrodes implanted in the brains of patients being evaluated for epilepsy treatment to study what parts of the brain were involved when those patients read words and sentences. They found that two different parts of the brain are activated, and interact in different ways when you read a simple list of unrelated words, compared to when you encounter a series of words that builds up a more complex idea. Dr. Nitin Tandon, a professor of neurosurgery at UTHealth Houston and one of the authors of a report on the work published in the Proceedings of the National Academy of Sciences, joins guest host Sophie Bushwick to talk about the study, and what scientists are learning about how the brain allows us to read.   Transcripts for each segment will be available the week after the show airs on sciencefriday.com.

Dr. Claudia Cotes joins the podcast to speak with Dorothy about her journey to becoming a radiologist. She's an alum of The Rose and assistant professor at the Department of Diagnostic and Interventional Imaging at UTHealth Houston.  It's her job to tell women they have breast cancer. But the person she worries about the most is the caretaker.   Find out why during this wide ranging conversation, which also includes Dr. Cotes's path to becoming a distinguished radiologist. Please be sure to rate and review the podcast on your provider of choice and share with those in your community. The information could literally save a life. We also encourage you to learn more about The Rose's mission to help women by going to our website.See omnystudio.com/listener for privacy information.

On today's episode, I'm talking to orthopedic surgeon Dr. Bonnie Gregory about celebrating your accomplishments. Bonnie is an assistant professor of orthopedics at McGovern Medical School at UTHealth Houston and a team physician for several teams including the Houston Dash and the Houston Rockets. She's also a member of the Ruth Jackson Orthopaedics Society and part of the just 6% of orthopedic surgeons who are women. Throughout the interview, Bonnie shares with us how important celebrating your accomplishments can be because it gives us a moment away from focusing on what comes next and allows us to check in with our trajectory and make sure that it's really in line with our mission and vision.We talk about:Bonnie's journey to discovering orthopedics and how there is almost no single correct path to a given career.How participating in leadership programs helped Bonnie discover her leadership style but also taught her the importance of understanding the rules of the game in order to break the ones that were no longer working.As a woman physician covering teams ranging from the NBA to high school football, Bonnie is helping to change perceptions of what a team physician looks like, opening the doors for a new generation of physicians who look, think, and speak more like the patients they serve. Grab my free exercise to help you define your specific and unique values to help make sure you're staying in alignment with your mission and vision.You can find the show notes and more resources at https://madamathlete.comKeep an eye out for new content or let us know what you'd like to see next by following us on social:Instagram: @theMadamAthleteFacebook: @MadamAthleteTwitter: @MadamAthlete

Town Square with Ernie Manouse airs at 3 p.m. CT. Tune in on 88.7FM, listen online or subscribe to the podcast. Join the discussion at 888-486-9677, questions@townsquaretalk.org or @townsquaretalk. COVID cases and hospitalizations are on the rise, in part to the new variant XBB.1.5. Dr. James McDeavitt explains the traits of this new variant, how easily it's transmitted and the effectiveness of the vaccine.  Plus, he discusses long COVID and what we can expect from future mutations of the virus.  Dr. McDeavitt also weighs in on the surge of COVID-related deaths in China and how they're dealing with the overwhelming death toll they're experiencing in the aftermath of moving away from their strict zero-COVID policy. Then, Dr. Michael Chang continues the conversation with his thoughts on how COVID symptoms have changed throughout the pandemic and answers questions from listeners about long COVID. Plus, Dr. Chang shares the latest on the flu and RSV and if they have waned from its peak before the holiday season. To learn how you can stay up to date on COVID vaccines based on manufacturer and previous doses, click here. Guests: Dr. James McDeavitt Executive Vice President and Dean of Clinical Affairs, Baylor College of Medicine Dr. Michael Chang, MD Pediatric Infectious Diseases Physician at UTHealth Houston and Children's Memorial Hermann Hospital Town Square with Ernie Manouse is a gathering space for the community to come together and discuss the day's most important and pressing issues. We also offer a free podcast here, on iTunes, and other apps

In this episode, you'll hear from Claire Lawrence who is the Academic and Admissions Advisor at the University of Texas Health Science Center at Houston School of Public Health. You'll hear her discuss: how organic social content plays a role in their digital strategy their grassroots approach to recruiting public health students the challenges they face with increased competition

We have another Grand Rounds follow up interview for you today, and a special one at that! Dr. Jared Chen has joined the Stroke Institute here at UTHealth Houston and we were so thankful not only for his time spent on his Grand Rounds presentation, but for sticking around for an in-depth look into his research and new faculty position. One of this year's Stroke Institute fellows, Mohammad Rauf, discussed Intracerebral Hemorrhage Therapies with Dr. Chen, past, present, and future, and we hope you enjoy, and share with colleagues. ____________________________________ Twitter: @UTHealthStroke Instagram: @UTHealthStroke Facebook: facebook.com/uthealthstroke Ideas and opinions are our own and this podcast is not a substitute for expert medical advice. About StrokeBusters is a podcast series of recorded conversations on the topic of stroke and cerebrovascular disease. Based in the Texas Medical Center, the largest medical center in the world, we tap into our local network of astonishing leaders in healthcare and medicine to discuss the latest and most exciting news on stroke. Throughout this ten-episode series, we connect with UTHealth physicians and researchers, many of who are experts in their field, to discuss their practice, cutting-edge research, and medical care. Who We Are The Institute for Stroke and Cerebrovascular Disease, better known as the Stroke Institute, serves as a multi-disciplinary hub for research and best practices in stroke recovery, stroke prevention, services, population health, and vascular dementia. We are one of the most active research and clinical programs in the country, the first Comprehensive Stroke Center in the state, and launched the first Mobile Stroke Unit in the nation. Our stroke program, founded by Dr. James Grotta in 1979, specializes in stroke epidemiology, clinical trial design, and basic science. We train the next generation of revolutionary academics and leaders in cerebrovascular disease through our NINDS-funded fellowship programs. Contact For more information or if you have any questions, please contact us at info.uthiscd@gmail.com

We sat down with Madisyn Cox, the 10x NCAA All-American and 5x World Champ medalist who recently announced her retirement from swimming. Cox takes us through the last year of her career, from her last meet at the Texas Swim Center, where she went 3 lifetime bests, to the Olympic Trials, where she was .02 off of making the 2020 Olympic team. She also discusses what her life looks like now that she is living in Houston and attending UTHealth Houston.

Town Square with Ernie Manouse airs at 3 p.m. CT. Tune in on 88.7FM, listen online or subscribe to the podcast. Join the discussion at 888-486-9677, questions@townsquaretalk.org or @townsquaretalk. We kick off a brand new season of Town Square with Ernie Manouse covering a broad range of topics: health and wellness, education, and politics.  We start the discussion with the latest on COVID, new boosters targeting the omicron variant, monkeypox, and preparation for the flu season.  Plus, what do parents need to know to keep their kids healthy this school year. Now that school is in session, we discuss the challenges facing teachers, including school safety, censorship of books and the new “In God We Trust” law in Texas. We also examined the appointment of an independent special master to look over the documents seized by the FBI at President Trump's estate, Mar-a-Lago. Guests: Dr. Michael Chang • Pediatric Infectious Disease Specialist, UTHealth Houston and Children's Memorial Hermann Hospital Zeph Capo • President, Texas American Federation of Teachers Dr. Frank Sorrentino • Professor Emeritus at St. Francis College Author, Presidential Power and the American Political System Town Square with Ernie Manouse is a gathering space for the community to come together and discuss the day's most important and pressing issues. We also offer a free podcast here, on iTunes, and other apps.

In today's episode, Dr. Seema Aggarwal sat down with Dr. Yejin Kim to discuss Dr. Kim, along with many other UTHealth Houston and Stroke Institute researchers, an article from March 2022, a counterfactual analysis of differential comorbidity risk factors in Alzheimer's disease and related dementias. Their analysis discovered different comorbidities that predispose older African Americans to AD compared to Caucasian counterparts. The findings from their study, which used data collected from nationwide electronic health records will assist in developing a targeted treatment for AD. Their discussion also provided great insight into the processes Kim and her team went through to complete their study and their hopes for applications in the future. __________ The Institute for Stroke and Cerebrovascular Disease (UTHealth Stroke Institute) http://www.utstrokeinstitute.com/ Host: Seema Aggarwal, PhD, APRN, AGNP-C Guest: Yejin Kim, PhD Twitter: @UTHealthStroke Instagram: @UTHealthStroke Facebook: facebook.com/uthealthstroke Ideas and opinions are our own and this podcast is not a substitute for expert medical advice. About StrokeBusters is a podcast series of recorded conversations on the topic of stroke and cerebrovascular disease. Based in the Texas Medical Center, the largest medical center in the world, we tap into our local network of astonishing leaders in healthcare and medicine to discuss the latest and most exciting news on stroke. Throughout this ten-episode series, we connect with UTHealth physicians and researchers, many of who are experts in their field, to discuss their practice, cutting-edge research, and medical care. Who We Are The Institute for Stroke and Cerebrovascular Disease, better known as the Stroke Institute, serves as a multi-disciplinary hub for research and best practices in stroke recovery, stroke prevention, services, population health, and vascular dementia. We are one of the most active research and clinical programs in the country, the first Comprehensive Stroke Center in the state, and launched the first Mobile Stroke Unit in the nation. Our stroke program, founded by Dr. James Grotta in 1979, specializes in stroke epidemiology, clinical trial design, and basic science. We train the next generation of revolutionary academics and leaders in cerebrovascular disease through our NINDS-funded fellowship programs. Contact For more information or if you have any questions, please contact us at info.uthiscd@gmail.com

I love this episode because Texas schools are so great! You will definitely want to hear about rotations at MD Anderson, affordable tuition, and more!

In this episode, we welcome Patricia Hinojosa, Director of Payroll & Benefits at UTHealth Houston to share her wisdom and experience to help us find ways to prioritize our work/life resources so we can manage unexpected life events.

Town Square with Ernie Manouse airs at 3 p.m. CT. Tune in on 88.7FM, listen online or subscribe to the podcast. Join the discussion at 888-486-9677, questions@townsquaretalk.org or @townsquaretalk. Obesity rates are climbing in the United States, with Texas higher than the national average at the 30-49 percent range.  As more Americans face weight challenges, a new wave of medical understanding challenges the causes, contributions, and social stigma about weight management.  Dr. Nik Dhurandhar Chair of the Department of Nutritional Sciences at Texas Tech University Editor In Chief of the International Journal of Obesity Past president of The Obesity Society Dr. Sameer Murali Obesity medicine specialist at UTHealth Houston Dr. Jennifer Bahrman Professor of psychiatry at UTHealth Houston This episode of Town Square is guest-hosted by Brenda Valdivia, in for Ernie Manouse. Town Square with Ernie Manouse is a gathering space for the community to come together and discuss the day's most important and pressing issues. Audio from today's show will be available after 5 p.m. CT. We also offer a free podcast here, on iTunes, and other apps.

BUFFALO, NY- June 8, 2022 – A research paper was recently published in Oncotarget, entitled, “A novel group of genes that cause endocrine resistance in breast cancer identified by dynamic gene expression analysis.” Breast cancer (BC) is the most common type of cancer diagnosed in women. Among female cancer deaths, BC is the second leading cause of death worldwide. For estrogen receptor-positive (ER-positive) breast cancers, endocrine therapy is an effective therapeutic approach. However, in many cases, ER-positive tumors become unresponsive to endocrine therapy, and tumor regrowth can occur after treatment. While some genetic mutations contribute to resistance in some patients, the underlying causes of resistance to endocrine therapy are mostly undetermined. “Endocrine therapies have been successful at improving cancer outcomes; however, the development of endocrine resistance, or resistance to inhibition of ER actions, remains a roadblock in breast cancer treatment.” In the current study, researchers from UTHealth Houston, University of Chicago, University of Texas MD Anderson Cancer Center, and the University of Houston explored the dynamic behavior of the entire gene population to identify novel genes that play fundamental roles in the development and progression of endocrine-resistant breast cancer. “In this study, we utilized a recently developed statistical approach to investigate the dynamic behavior of gene expression during the development of endocrine resistance and identified a novel group of genes whose time course expression significantly change during cell modelling of endocrine resistant BC development.” To better understand the process of acquiring endocrine resistance and its underlying gene expression patterns, the researchers applied their recently developed statistical pipeline to datasets from a public functional genomics repository. They found dynamically regulated genes active in the process of endocrine resistance development and progression. Their dynamic gene expression analysis identified 34 novel genes that significantly changed during cell modeling of endocrine-resistant breast cancer development. Expression of a subset of these genes was also differentially expressed in microarray analysis of endocrine-resistant and endocrine-sensitive tumor samples. Surprisingly, a subset of those genes was also differentially expressed in triple-negative breast cancer (TNBC) as compared with ER-positive BC. “The findings suggest shared genetic mechanisms may underlie the development of endocrine resistant BC and TNBC.” DOI: https://doi.org/10.18632/oncotarget.28225 Correspondence to: Michihisa Umetani – mumetani@uh.edu, and Vahed Maroufy – Vahed.Maroufy@uth.tmc.edu Special Collection on Breast Cancer: https://www.oncotarget.com/collections/breast-cancer/ Keywords: breast cancer, triple negative breast cancer, gene expression profiling, endocrine resistance, gene clustering About Oncotarget: Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science. To learn more about Oncotarget, visit Oncotarget.com and connect with us on social media: Twitter – https://twitter.com/Oncotarget Facebook – https://www.facebook.com/Oncotarget YouTube – www.youtube.com/c/OncotargetYouTube Instagram – https://www.instagram.com/oncotargetjrnl/ LinkedIn – https://www.linkedin.com/company/oncotarget/ Pinterest – https://www.pinterest.com/oncotarget/ LabTube – https://www.labtube.tv/channel/MTY5OA SoundCloud – https://soundcloud.com/oncotarget For media inquiries, please contact: media@impactjournals.com.

May is Stroke Awareness Month and we are excited to bring to you a mini-series this month focused on Careers in Stroke. Each episode we'll talk with professionals, doctors, researchers and therapists who work with stroke patients and in stroke science. Highlighting the people who work in stroke care, hear their stories, why they chose their career paths, hopefully this encourages future generations of stroke professionals! Starting our Careers in Stroke mini-series, we spoke with Emily Stevens, OTR, from the Stroke Institute at UTHealth Houston. The Institute for Stroke and Cerebrovascular Disease (UTHealth Stroke Institute) http://www.utstrokeinstitute.com/ Hosts: Amy Quinn Twitter: @UTHealthStroke Instagram: @UTHealthStroke Facebook: facebook.com/uthealthstroke Ideas and opinions are our own and this podcast is not a substitute for expert medical advice.

Listen to a blog summary of a recent research paper published in Volume 13, entitled, "A novel group of genes that cause endocrine resistance in breast cancer identified by dynamic gene expression analysis." _________________________________ Hormones can cause tumor growth in some subtypes of breast cancer. Endocrine therapy, also known as hormone therapy, is a type of cancer treatment that removes or blocks the hormones which fuel breast cancer growth. This treatment is often given as adjuvant therapy after breast cancer surgery to lower the risk of cancer reoccurrence. In some cases, endocrine therapy may be used as a first-line treatment for hormone receptor-positive breast cancers, such as estrogen receptor-positive (ER-positive) breast cancers. However, ER-positive tumors frequently become unresponsive to endocrine therapy, and tumor regrowth can occur after treatment. The underlying causes of endocrine resistance are mostly undetermined. “Endocrine therapies have been successful at improving cancer outcomes; however, the development of endocrine resistance, or resistance to inhibition of ER actions, remains a roadblock in breast cancer treatment.” Recently, researchers—from UTHealth Houston, University of Chicago, University of Texas MD Anderson Cancer Center, and the University of Houston—used a new statistical and computational pipeline method of analysis to study the dynamic behavior of gene expression during the development of endocrine resistance in breast cancer. Their trending research paper published in Oncotarget on April 06, 2022, is entitled, “A novel group of genes that cause endocrine resistance in breast cancer identified by dynamic gene expression analysis.” Full blog - https://www.oncotarget.org/2022/04/14/trending-with-impact-genes-identified-in-endocrine-therapy-resistance/ DOI - https://doi.org/10.18632/oncotarget.28225 Correspondence to - Michihisa Umetani - mumetani@uh.edu, and Vahed Maroufy - Vahed.Maroufy@uth.tmc.edu Sign up for free Altmetric alerts about this article - https://oncotarget.altmetric.com/details/email_updates?id=10.18632%2Foncotarget.28225 Keywords - breast cancer, triple negative breast cancer, gene expression profiling, endocrine resistance, gene clustering About Oncotarget Oncotarget is a peer-reviewed, open access biomedical journal covering research on all aspects of oncology. To learn more about Oncotarget, please visit https://www.oncotarget.com and connect with us: SoundCloud - https://soundcloud.com/oncotarget Facebook - https://www.facebook.com/Oncotarget/ Twitter - https://twitter.com/oncotarget Instagram - https://www.instagram.com/oncotargetjrnl/ YouTube - https://www.youtube.com/OncotargetYouTube LinkedIn - https://www.linkedin.com/company/oncotarget Pinterest - https://www.pinterest.com/oncotarget/ Reddit - https://www.reddit.com/user/Oncotarget/ Oncotarget is published by Impact Journals, LLC: https://www.ImpactJournals.com Media Contact MEDIA@IMPACTJOURNALS.COM 18009220957

In this episode, Andrea Ancer Leal, RN, LMSW, BSN-DNP Student and Research Coordinator II with the Cizik School of Nursing at UTHealth Houston, sits down with Miguel A. De La Mora, Psychiatric Nurse Practitioner DNP Student at UTHealth Cizik School of Nursing to recap our previous episode on Post-Stroke Depression and Anxiety, with Dr. Jennifer Beachamp, in Spanish. Ideas and opinions are our own and this podcast is not a substitute for expert medical advice. The Institute for Stroke and Cerebrovascular Disease (UTHealth Stroke Institute) http://www.utstrokeinstitute.com/ UTHealth Stroke Institute Vascular Neurology Fellowship https://www.uth.edu/stroke-institute/training/vascular-neurology-fellowship Host: Amy Quinn Communications Director, The Institute for Stroke and Cerebrovascular Disease at UTHealth Houston Twitter: @UTHealthStroke Instagram: @UTHealthStroke Facebook: facebook.com/uthealthstroke

In this episode we chat with Dr. Louise McCullough, professor and Chair of Neurology at Memorial Hermann Hospital in the Texas Medical Center and Co-Director of UTHealth Neurosciences. She is also the Conference Chair for this year's International Stroke Conference and offers an inside look into this year's event and UTHealth Houston's involvement. We discuss COVID and stroke, Dr. James Grotta's presentation on MSU cost effectiveness, TNK vs TPA use, up and comers from UTHealth Houston to look out for and so much more. Ideas and opinions are our own and this podcast is not a substitute for expert medical advice. The Institute for Stroke and Cerebrovascular Disease (UTHealth Stroke Institute) http://www.utstrokeinstitute.com/ UTHealth Stroke Institute Vascular Neurology Fellowship https://www.uth.edu/stroke-institute/training/vascular-neurology-fellowship Dr. Louise McCullough https://med.uth.edu/neurology/faculty/louise-d-mccullough-md-phd/ Host: Amy Quinn Communications Director, The Institute for Stroke and Cerebrovascular Disease at UTHealth Houston Twitter: @UTHealthStroke Instagram: @UTHealthStroke Facebook: facebook.com/uthealthstroke

On this week's episode of "Getting to the Bottom of It," podcast host Alec Rich speaks with Daphne Hernandez, associate professor at Cizik School of Nursing at UTHealth Houston and Sara Goldrick-Rab, professor of sociology and medicine at Temple University, about the university's new dining plan and food insecurity on campus.

Andrea and Orlando speak with Dr. Luis Ostrosky, chief of infectious diseases at McGovern Medical School at UTHealth Houston, about the current state of the COVID-19 pandemic and answers questions about masking and vaccines. The advice and answers are straightforward and unbiased! Watch TLC Live! On Facebook or on YouTube, and Comment Live on Facebook Every Wednesday at 11 AM!

In our first episode, Dr. Alexandra Czap, assistant professor of neurology and neurosurgery at UTHealth Houston, sits down with stroke expert and pioneer, Dr. James Grotta, to reflect on the past, present, and future of the stroke field. Dr. Grotta reminisces on the monumental changes within the field and provides insight on what stroke trainees should know to lead the next revolution of stroke. Ideas and opinions are our own and this podcast is not a substitute for expert medical advice. The Institute for Stroke and Cerebrovascular Disease http://www.utstrokeinstitute.com/ UTHealth Stroke Fellowship Program https://www.uth.edu/stroke-institute/training/vascular-neurology-fellowship Host: Barbra Ovuegbe Marketing Coordinator, UTHealth Houston Guest: Alexandra Czap, MD Assistant Professor of Neurology and Neurosurgery, UTHealth Houston https://www.uth.edu/stroke-institute/faculty/profile?id=a802edb7-9142-4118-bed5-2f0598cb6e89 Guest: James C. Grotta, MD Director of Stroke Research, Clinical Institute for Research and Innovation, Memorial Hermann - Texas Medical Center Director, Mobile Stroke Unit Consortium https://www.uth.edu/stroke-institute/faculty/profile?id=8f8c7729-0587-4ef5-b6c6-59c65a3e88af

  CCCT interviewed Clinton “Brooks” Herman from UTHealth in Houston. We discussed his construction resume from college education at Texas A&M, interning with Texas GC's to building retail boutique apparel to Big Box and now in the healthcare sector. Also covered was the private & public enterprise differences and what will come down the road for the healthcare sector in terms of construction & growth. To be a guest or sponsor on CCCT, please email your host David Corson at davidc@ccr-mag.com.